STOCK TITAN

Anterix Inc SEC Filings

ATEX NASDAQ

Welcome to our dedicated page for Anterix SEC filings (Ticker: ATEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Anterix Inc. (NASDAQ: ATEX) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K. These filings detail how Anterix describes its business as a provider of private 900 MHz licensed spectrum and advanced intelligent infrastructure solutions for utilities and other critical infrastructure sectors.

In its periodic reports, Anterix presents financial statements and notes that cover spectrum revenue, gains on exchange and sale of spectrum-related intangible assets, investments in spectrum clearing, deferred revenue, contingent liabilities, cash and cash equivalents, and other key balance sheet and income statement items. Investors can review these documents to understand the company’s spectrum assets, contracted proceeds from customers, and pipeline of prospective contract opportunities.

Current reports on Form 8-K for Anterix include disclosures about quarterly and annual financial results, leadership changes such as the appointment or resignation of executive officers, shareholder meeting outcomes, and changes in the company’s independent registered public accounting firm. These filings provide timely information about significant corporate events and governance matters.

On Stock Titan, Anterix filings are accompanied by AI-powered summaries that highlight the main points of lengthy documents, helping users quickly identify items such as revenue drivers, spectrum transactions, and notable risk factors. Real-time updates from the SEC’s EDGAR system ensure that new 10-K, 10-Q, and 8-K filings, as well as other relevant forms, appear promptly. Users can also review insider-related disclosures when they are filed, gaining additional context on executive and director activity related to ATEX.

Rhea-AI Summary

BlackRock, Inc. filed an Amendment No. 3 to Schedule 13G/A reporting beneficial ownership of 4.98% of Anterix Inc. common stock, equal to 934,649 shares. The filing shows BlackRock holds 934,649 shares with sole voting power on 922,145 shares and sole dispositive power on 934,649 shares. The schedule states ownership is held by certain Reporting Business Units and was signed on 04/27/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Anterix Inc. filed an amended current report to correct a fact sheet about its spectrum sale to Public Utility District No. 1 of Benton County. The incorrect $13 million contract bullet was removed and replaced with the actual $771,000 total payment under the Benton Agreement.

Through its PDV subsidiary, Anterix agreed to sell Benton PUD a 10 MHz 900 MHz spectrum license covering Benton County, Washington. The deal supports a private wireless broadband network for a 927-square-mile service area serving more than 58,000 customers, with spectrum delivery contemplated within 18 months of contract execution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.62%
Tags
current report
-
Rhea-AI Summary

Anterix Inc. entered into a spectrum license sale agreement with Public Utility District No. 1 of Benton County in Washington. Through its subsidiary PDV Spectrum Holding Company, Anterix will sell a 10 MHz, 900 MHz broadband spectrum license covering Benton County for total payments of $771,000.

The utility-owned, utility-controlled private wireless network will support Benton PUD’s 927-square-mile service territory and more than 58,000 customers, enabling advanced grid automation, field workforce connectivity, and improved outage detection and restoration. Delivery of the broadband spectrum is contemplated to occur within 18 months of contract execution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.62%
Tags
current report
Rhea-AI Summary

ATEX filed a Form 144 reporting proposed and recent sales of Common stock. The notice lists 25,000 shares associated with Morgan Stanley Smith Barney LLC and two issuer stock option exercises of 8,000 and 17,000 shares on 04/17/2026. It also discloses three recent sales by Ryan L. Gerbrandt: 26,889, 22,595, and 28,518 shares on 04/16/2026, 03/02/2026, and 02/19/2026, respectively.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

The issuer submitted a Form 144 notice to sell 26,889 shares via a stock option exercise for cash, dated 04/16/2026. The filing lists prior sales in the past three months: 22,595 shares on 03/02/2026 and 28,518 shares on 02/19/2026, with reported aggregate values shown in the excerpt.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Anterix Inc. disclosed that its wholly owned subsidiary, PDV Spectrum Holding Company, LLC, entered into a 900 MHz spectrum license sale agreement with NorthWestern Energy. The deal supports deployment of a mission-critical private wireless broadband network across portions of Montana, South Dakota, and Wyoming.

The agreement includes a total contract price of $7.7 million, with an initial payment at signing and final payments as the FCC grants broadband licenses and spectrum is assigned between 2026 and 2033. Anterix will clear existing incumbents from the 900 MHz band and work with NorthWestern Energy to secure the required broadband licenses, with customary remedies and termination rights if either party fails to perform.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
current report
Rhea-AI Summary

Anterix Inc. entered into a 900 MHz spectrum license sale agreement with Texas-New Mexico Power, enabling TNMP to deploy a mission-critical private wireless network to bolster grid reliability and resiliency in parts of Brazoria and Galveston counties in Texas.

The agreement assigns 6 MHz of broadband spectrum for a total contract price of $3.2 million, with a phased delivery starting in 2027 and full delivery targeted by December 31, 2028. Payments are tied to milestones, including FCC broadband license grants and spectrum delivery, and include customary remedies and termination rights.

Anterix and TNMP also signed a Memorandum of Understanding to negotiate a master agreement for deployment accelerators, such as device and connectivity management and tower access, supporting TNMP’s 2025-2027 System Resiliency Plan to improve outage response, real-time monitoring, and integration of advanced energy technologies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.41%
Tags
current report
-
Rhea-AI Summary

Anterix Inc. Chief Legal Officer and Corporate Secretary Gena L. Ashe reported option-related transactions in company stock. On March 3, 2026, Ashe exercised stock options for 12,427 shares, converting them into an equal number of Anterix common shares at an exercise price of $27.83 per share.

On the same date, 12,427 common shares were disposed of in a transaction coded as a tax-withholding event, using shares to satisfy the exercise price or tax obligations. Following these transactions, Ashe directly owned 13,366 shares of Anterix common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

ATEX insider notice: 22,595 shares of common stock were reported as to be sold in a stock option exercise on 03/02/2026 for cash. The filing also records a prior sale of 28,518 shares on 02/19/2026 for $975,560.85.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many Anterix (ATEX) SEC filings are available on StockTitan?

StockTitan tracks 41 SEC filings for Anterix (ATEX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Anterix (ATEX)?

The most recent SEC filing for Anterix (ATEX) was filed on April 27, 2026.